Breaking News
0

What's In Store For Assurant (AIZ) This Earnings Season?

By Zacks Investment ResearchStock MarketsAug 01, 2019 10:28PM ET
www.investing.com/analysis/whats-in-store-for-assurant-aiz-this-earnings-season-200450030
What's In Store For Assurant (AIZ) This Earnings Season?
By Zacks Investment Research   |  Aug 01, 2019 10:28PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Assurant, Inc. (NYSE:AIZ) is slated to report second-quarter 2019 results on Aug 6, after market close. The company delivered positive earnings surprise in each of the last four reported quarters.

Let’s see how things are shaping up for this announcement.

Assurant is likely to benefit from solid results at Global Lifestyle, Housing and Preneed business lines. The acquisition of The Warranty Group (TWG) is also likely to contribute.

Global Lifestyle is expected to continue to benefit from growth at Connected Living and Global Automotive. The company’s efforts to collaborate with leading brands to bring innovative products and services will provide support.

Global Housing is likely to benefit from expansion of specialty offerings, multifamily housing, in particular realignment of business and implementation of different expense management initiatives across the segment. However, the company estimates higher non-cat loss ratios in the second quarter of 2019. The company expects lender-placed earnings to reflect additional reinsurance coverage that it acquired in early 2019.

Improved interest rate environment and higher invested assets are expected to support investment results.

All these factors combined are likely to drive revenue improvement. The Zacks Consensus estimate for revenues is pegged at $2.3 billion, indicating 28.2% increase from the year-ago reported figure.

However, expenses are likely to increase given higher policyholder benefits, selling, underwriting, general and administrative expenses as well as interest expense.

Continued share buybacks should aid the bottom line.

The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $2.13, implying an increase of nearly 1% from the year-ago reported figure.

What Our Quantitative Model States

Our proven model does not conclusively show that Assurant is likely to beat on earnings in the to-be-reported period. This is because a stock needs to have both a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.

Earnings ESP: Assurant has an Earnings ESP of 0.00%. This is because the Most Accurate Estimate as well as the Zacks Consensus Estimate is pegged at $2.13. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Assurant currently carries a Zacks Rank #3. Though Zacks Rank #1, 2 or 3 increases the predictive power of ESP, the company’s ESP of 0.00% makes surprise prediction difficult.

We caution against Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks going into an earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks to Consider

Some stocks from the insurance industry with the perfect mix of elements to outshine estimates this time around are as follows:

Voya Financial (NYSE:VOYA) is set to report second-quarter earnings on Aug 6. The company has an Earnings ESP of +1.42% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

American Financial Group (NYSE:AFG) has an Earnings ESP of +0.66% and a Zacks Rank of 3. The company is scheduled to release second-quarter earnings on Aug 6.

American International Group (NYSE:AIG) has an Earnings ESP of +0.09% and a Zacks Rank of 2. The company is slated to announce second-quarter earnings on Aug 7.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Voya Financial, Inc. (VOYA): Free Stock Analysis Report

Assurant, Inc. (AIZ): Free Stock Analysis Report

American International Group, Inc. (AIG): Free Stock Analysis Report

American Financial Group, Inc. (AFG): Free Stock Analysis Report

Original post
What's In Store For Assurant (AIZ) This Earnings Season?
 
What's In Store For Assurant (AIZ) This Earnings Season?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email